Avacta Group plc Investor Webinar

Investor webinar presented by Dr Christina Coughlin, Chief Executive Officer, and Michelle Morrow, Chief Scientific Officer, Avacta Therapeutics (AIM: AVCT), chaired by experienced news and corporate events presenter Katie Pilbeam (www.katiepilbeam.com).

The webinar focused on the Company’s recent data presentations on its proprietary pre|CISION® candidates FAP-Dox (AVA6000) and FAP-EXd (AVA6103) at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, USA.

Turner Pope Investments hosted the Investor Webinar on Thursday, 15th May 2025 at 6.00 pm

Access our research notes: